联系电话:512-67626747 联系邮箱:eegene215@qq.com
合作厂商登彔/苏州翊准基因科技有限公司

DPYD, TYMS, TYMP, TK1, AND TK2 GENETIC EXPRESSIONS AS RESPON

发布时间:2016-10-24 ??? 阅读数:

 DPYD, TYMS, TYMP, TK1, and TK2 Genetic Expressions as Response Markers in Locally Advanced Rectal Cancer Patients Treated with Fluoropyrimidine-Based Chemoradiotherapy

 
Ming-Yii Huang,1,2,3 Chan-Han Wu,4 Chun-Ming Huang,1,2
Fu-Yen Chung,4 Ching-Wen Huang,5,6,7 Hsiang-Lin Tsai,3,5,8 Chin-Fan Chen,9
Shiu-Ru Lin,4 and Jaw-Yuan Wang3,5,6,9,10,11
 
Received 6 November 2013; Accepted 22 November 2013
 
Abstract:This study is to investigate multiple chemotherapeutic agent- and radiation-related genetic biomarkers in locally advanced rectal cancer (LARC) patients following fluoropyrimidine-based concurrent chemoradiotherapy (CCRT) for response prediction. We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, TYMS, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1

上一篇:分子标记抽血检测 有助肠癌早期诊断
下一篇:SIGNIFICANT OVEREXPRESSION OF DVL1 IN TAIWANESE COLORECTAL C

  • 苏州翊准基因科技
    中国江苏省苏州市工业园区新平街388号B幢B-203(腾飞创新园塔楼B-203)
    电话:86-512-67626747
    传真:86-512-67626747
    QQ:2957745965

Copyright © 2016 苏州翊准基因科技有限公司 版权所有 苏ICP备17013352号

夜夜橾天天橾b在线观看